Stockwatch: biotech stocks propped by dubious market research
This article was originally published in Scrip
This is the time of year when I supervise MPhil students from the University of Cambridge who are researching and writing their dissertations. At this level, students should be able to demonstrate some quantitative analysis. In an assignment that only lasts a few months, that usually means that they conduct some primary market research. Thankfully, students can learn from my mistakes: I never want them to have that nauseous feeling you get when you read the results of a $30,000 market research study and realize that you did not have the most commercially important question in the questionnaire.